RENT.COM.AU LIMITED — Director's Dealing 2005

Aug 25, 2005

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity: Select Vaccines Limited
ABN:	25 062 063 692

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Robin Beaumont
Date of last notice	5 July 2005

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be
disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest	Director related entity
Date of change	25 August 2005 a) 25 August 2005 b)
No. of securities held prior to change	Direct Indirect	Shares 125,000	Options
Class	Shares
Number acquired	Direct Indirect	Shares 75,000	Options
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Purchase 35,019 shares at \$0.225 per a) share Purchase 39,981 shares at \$0.22 per b) share

⁺ See chapter 19 for defined terms.

No. of securities held after change	Direct Indirect	Shares 200,000	Options
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securifies under dividend reinvestment plan, participation in buy-back-	a) b) On market trade	On market trade

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	As per Letter of Appointment:
	500,000 options exercisable at \$0.30 on or before 31
	May 2008, subject to shareholder approval at next
	general meeting
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to	N/A
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change	N/A

The CFO Solution www.cfo.com.au
26 August 2005

$+$ See chapter 19 for defined terms.